Metraipolis › archive › dc_a7e671e14540
Ogilvie Syndrome: A Therapeutic Challenge — Europe PMC PMID:41869177
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41869177
- DOI
- 10.7759/cureus.103754
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-05T17:38:54.559Z
- SHA-256 of the archived text
37292b14cb3e1bd527d02dea05d0204693e9cf5d8fa3f230cf4bc16a2e32febc- Stable URL of this page
https://metraipolis.com/documento/dc_a7e671e14540
How to cite
Ogilvie Syndrome: A Therapeutic Challenge — Europe PMC PMID:41869177 — Europe PMC (en), https://europepmc.org/article/MED/41869177 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_a7e671e14540 (Metraipolis archive dc_a7e671e14540, sha256 37292b14cb3e1bd527d02dea05d0204693e9cf5d8fa3f230cf4bc16a2e32febc)
BibTeX
@misc{dca7e671e14540,
title = {Ogilvie Syndrome: A Therapeutic Challenge — Europe PMC PMID:41869177},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41869177},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_a7e671e14540; sha256 37292b14cb3e1bd527d02dea05d0204693e9cf5d8fa3f230cf4bc16a2e32febc},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41869177. Agents can read the archived copy with the MCP tool read_document.